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Previous reports on the patient perspective of daily life during a 1- year high- grade 
glioma (HGG) trajectory from the time of diagnosis are sparse. The aim of this longitu-
dinal mixed methods study is to identify the specific needs and preferences for reha-
bilitation and supportive care and how it links with physical activity, psychological 
measures and health quality longitudinally over the first year after diagnosis among 
patients with HGG and their caregivers by integrating qualitative and quantitative 
findings. Using a longitudinal mixed methods design, patients with malignant glioma 
(n = 30) and their caregivers (n = 33) were interviewed and completed questionnaires 
(patients only) about physical activity level, anxiety/depression and quality of life five 
times during the 1- year period. Their needs and preferences included interventions 
designed to re- define hope after diagnosis, health promoting physical activities initi-
ated early, psychological symptom management strategies, and life planning. 
Caregivers are committed to their caregiving role, but their engagement is nonetheless 
challenged over time by enormous caregiver burdens. The identified specific needs 
and preferences favour supportive care, education, information and rehabilitation. 
Guidelines attentive to these needs and implemented in clinical practice have the po-
tential to improve patients’ health- related quality of life and support caregivers by in-
volving them more actively in care and management.
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1  | INTRODUCTION
International research continues to contribute to an evidence- based 
clinical practice for supportive care and rehabilitation in patients diag-
nosed	with	high-	grade	glioma	(HGG)	(Australian	Cancer	Network	Adult	
Brain Tumour Guidelines Working Party, 2009; Weller et al., 2014). HGG 
is a rapidly progressive life- threatening disease with a poor prognosis 
(Wen & Kesari, 2008) being the most aggressive type of primary brain 
tumours (Weller et al., 2014). The most common malignant tumor is 
glioblastoma	(45.6%;	Louis	et	al.,	2016).	The	relative	survival	estimates	
for glioblastoma are low with a 5% survival rate after 5 years (Ostrom 
et al., 2014). Standard initial treatment for HGG involves surgery either 
as diagnostic biopsy or maximal surgical resection. The Stupp regimen 
including concomitant chemoradiotherapy followed by adjuvant main-
tenance chemotherapy with temozolomide is currently the standard 
post- operative treatment (Stupp et al., 2009). Despite this aggressive 
oncological treatment patients have a limited life span, maintenance 
of quality of life being an important endpoint (Ownsworth, Hawkes, 
Steginga, Walker, & Shum, 2009). Unfortunately, quality- of- life in the 
HGG population and their caregivers remains understudied compared 
to	other	groups	with	a	life-	threatening	cancer	diagnosis.	A	study	based	
upon experiences from patients with lung cancer found that the pa-
tients’ main concerns include fear of losing independence and being a 
burden for their relatives (Gralla, Hollen, Msaouel, Davis, & Petersen, 
2014). While this also may be of importance for patients with HGG, 
the situation is far more complicated as brain cancer often leads to 
cognitive deficits (e.g., personality changes) and physical impairments 
resulting in the closest relative becoming the caregiver.
Health-	related	 quality	 of	 life	 (HRQOL)	 has	 become	 a	 particu-
larly important clinical endpoint in the HGG trajectory. The under-
standing of both the patient and caregiver needs using objective 
measures	 of	 key	 physical,	 psychological	 and	 HRQOL	 is	 impera-
tive for an even more robust understanding of how the situation 
evolves	over	 time.	Survival	and	HRQOL	are	negatively	 influenced	
by the complexity of symptoms and complications. Impairment of 
physical condition and fatigue (Giovagnoli, Silvani, Colombo, & 
Boiardi, 2005; Mauer et al., 2007) lead to severe limitations in daily 
activities	and	reduced	QOL	(Jones	et	al.,	2010).	In	our	previous	lon-
gitudinal qualitative study we interviewed patients with HGG and 
their caregivers, and identified a need for information and guidance 
regarding symptoms and supportive care interventions (Piil, Juhler, 
Jakobsen, & Jarden, 2015). In the same population we quantita-
tively	measured	HRQOL	over	time	and	found	high	levels	of	anxiety	
among the newly diagnosed patients (Piil, Jakobsen, Christensen, 
Juhler, & Jarden, 2015).
This article seeks to expand our understanding of the complexity 
of the condition for the HGG patients and their caregivers by draw-
ing meta- inferences through the integration of these qualitative and 
quantitative findings (Fetters, Curry, & Creswell, 2013). Mixed meth-
ods (MM) researchers use meta- inferences to understand how com-
bining the findings from the qualitative and quantitative data can add 
value and provide deeper insight and knowledge (Creswell & Plano 
Clark, 2011).
Thus, the aim of this longitudinal MM study is to identify the spe-
cific needs and preferences for rehabilitation and supportive care and 
describe its association with physical activity, psychological measures, 
and health quality longitudinally over the critical first year after diag-
nosis of HGG for patients and their caregivers by extending beyond 
the previous quantitative and qualitative analyses, and integrating the 
qualitative and quantitative findings.
2  | MATERIALS AND METHODS
2.1 | Study design
In this longitudinal MM study, we collected concurrently qualita-
tive and quantitatively data. Prospectively, the qualitative data 
were collected individually for patients and caregivers at the same 
five time- points during their illness trajectory to understand how 
their experiences with HGG evolved at the time of initial diagno-
sis, surgery, adjuvant chemotherapy, and post- treatment periods. To 
describe how the condition evolved quantitative data about anxi-
ety/depression,	 HRQOL	 and	 physical	 activity	 level	 were	 collected	
prospectively over a 1- year trajectory from the time of diagnosis. 
This	 study	 is	 registered	 by	 the	 Danish	 Data	 Protection	 Agency	
(2007- 58- 0015/30- 0758) and the Ethical Committee at the Capital 
Region of Denmark (H- 2- 2013- 135) and carried out in accordance 
with the Declaration of Helsinki.
2.2 | Participants and procedures
We recruited subjects consecutively from May to December 2012 
at	 the	 Department	 of	 Neurosurgery,	 Rigshospitalet	 University	 of	
Copenhagen. The recruited subjects served as the source of the MM 
sampling for both the qualitative and quantitative data collected at the 
same five time- points (Creswell, 2015).
The	inclusion	criteria	were	participants	≥18	years	of	age,	newly	
diagnosed with HGG, functionally able to care for themselves, mea-
sured	at	a	Karnofsky	performance	status	≥60	and	with	the	ability	to	
speak and understand Danish. Clinical specialists and a neuropsy-
chologist were consulted regarding whether patients with cognitive 
deficits were able to participate in the study or must be excluded 
due to severe cognitive deficits. Disease progression was not an 
exclusion	criterion.	Adult	relatives	were	eligible	if	they	were	named	
by the patient as the most involved caregiver(s). Patients without 
relatives could also be included. Patients and their caregivers were 
recruited on the first postoperative day and provided separate writ-
ten informed consent within 2 days prior to discharge from the hos-
pital. The principal investigator (KP) recruited the participants and 
conducted separate interviews with patients and caregivers. Thirty 
patients and 33 of their caregivers constitute the participants of this 
study. This sample size was chosen to ensure an adequate number of 
participants at all five time- points and for the achievement of data 
saturation. The sample size was based on an expected 50% attrition 
rate and a median survival time of 12–15 months (Wen & Kesari, 
2008).
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2.3 | Data collection and procedures
2.3.1 | Qualitative data collection: semi- structured 
individual interviews
This longitudinal MM study involved individual telephone interviews 
with HGG patients and their caregivers at five fixed time- points during 
a	1-	year	disease	and	treatment	trajectory	(Figure	1).	A	semi-	structured	
interview guide was applied for each interview (Piil, Jarden, Jakobsen, 
Christensen, & Juhler, 2013). The intent was to explore the perspectives 
at critical events (e.g. surgery, treatment and response scans) along the 
disease and treatment trajectory, starting at the time of diagnosis.
2.3.2 | Quantitative data collection: assessment 
instruments
The results from the quantitative data collection regarding physical 
activity	 levels,	 anxiety/depression	 and	 HRQOL	 relied	 on	 patient-	
reported outcomes (PROs) and were collected at the same five 
time- points as the scheduled interviews (Figure 1). The following 
 instruments were used:
1. Physical	 Activity—Questionnaire	 on	 leisure	 time	 physical	 activity	
level (Saltin & Grimby, 1968)
2. Anxiety/depression—The	 Hospital	 Anxiety	 and	 Depression	 Scale	
(HADS;	Snaith,	2003)
3. HRQOL—The	Functional	Assessment	of	Cancer	Therapy,	General	
and	Brain	(FACT-G	and	FACT-Br;	Weitzner	et	al.,	1995)
Patients received the validated questionnaires by mail at the five 
time- points before their interview with a written instruction explaining 
how to complete and return the response in an enclosed, addressed 
envelope. Socio- economic conditions, Karnofsky performance sta-
tus, disease and treatment variables were obtained from the medical 
records.
2.4 | Data analyses and interpretation
Full details of the analytic procedures for the qualitative findings from 
the interviews (Piil, Juhler, et al., 2015) and the quantitative results 
of	the	HRQOL	questionnaires	(Piil,	Jakobsen,	et	al.,	2015)	have	been	
published previously, but are reviewed succinctly below.
2.4.1 | Thematic analysis
Interview transcripts were imported into the software programme 
NVivo9	(Skorkjær	Binderkrantz	&	Bøgh	Andersen,	2011)	to	facili-
tate	analysis.	Two	researchers	(KP,	MJA)	iteratively	and	reflexively	
conducted the thematic analysis to ensure trustworthiness and re-
search integrity of the study (Polit & Beck, 2004). The iterative 
process of the thematic analyses was guided by Braun and Clarke 
(2014).
2.4.2 | Statistical analyses
Responses to the ordinal items of the leisure time physical activ-
ity	 scale,	 the	 HADS	 sub-	scales,	 the	 FACT-	Br	 sub-	scales	 and	 the	
Karnofsky performance status were analysed separately and have 
been described in detail elsewhere (Piil, Jakobsen, et al., 2015). 
Participants (n = 18) who completed all study requirements dur-
ing the 1- year study period form a subsample allowing for analyses 
of the differences between baseline mean scores (anxiety, depres-
sion,	FACT-	Br	sub-	scales,	FACT	Br	Trial	Outcome	Index)	and	1-	year	
follow- up assessments, analysed using paired t tests. The statistical 
analysis	 was	 performed	 with	 SAS	 statistical	 software,	 version	 9.3.	
p	≤	.05	were	considered	significant.
2.4.3 | Integration of qualitative and quantitative 
data through use of joint displays to draw  
meta- inferences
We used a qualitatively framed MM approach for integration 
(Creswell, 2015). This approach integrates the two datasets. The 
qualitative findings frame the integration because they provide a 
window for the development of experiences at the five critical in-
cidents. The quantitative measures provided additional objective 
details relative to the themes identified by the qualitative data 
(Onwuegbuzie	&	Leech,	2005)	and	expanded	the	description	 (Polit	
& Beck, 2012).
F IGURE  1 Data collection at five 
time- points along 1- year high- grade glioma 
trajectory. HGG: High-grade glioma; TP: 
Time-point.
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A	side-	by-	side	joint	display	facilitated	integration	through	compar-
ison,	interpretation,	and	representation.	A	joint	display	is	a	way	to	inte-
grate the qualitative and quantitative findings (Guetterman, Fetters, & 
Creswell, 2015), and has been defined as, “…bringing the data together 
through a visual means to draw out new insights beyond the infor-
mation gained from the separate quantitative and qualitative results” 
(Fetters et al., 2013).
To compare and link the data and in accordance with a quali-
tatively driven approach, we simultaneously examined the over-
arching findings of the qualitative interviews and the quantitative 
results by considering related domains. To build the joint display, 
the qualitative findings were placed in the first column, and the 
quantitative findings placed in the second column. The respective 
qualitative and quantitative findings were moved around within 
columns to juxtapose related information together in rows. Once, 
the two types of related data were juxtaposed, we interpretated 
the findings by looking for commonality between the two data-
sets based on the overarching findings of each one. When linked, 
as part of the qualitatively framed analysis, we then organised 
the material in an order appropriate for a narrative that could 
convey the integrated findings. By systematically linking the re-
lated findings together, we interpretated the respective meaning 
and draw meta- inferences, namely, the outcome of interpreting 
topically related qualitative and quantitative data (Guetterman 
et al., 2015).
Linking	both	types	of	data	for	interpretation	facilitated	a	theme	
by construct comparison for drawing overarching conclusions. 
Based on this juxtaposition, we could then draw conclusions about 
what the qualitative and the quantitative data were illustrating 
both individually and cumulatively (as meta- inferences) about the 
specific themes. These three elements, the qualitative findings, 
quantitative findings, and meta- inferences were then included in 
theme- related tables for results presentation. Merging data in this 
representation allowed us to look across the two types of data set 
to look for confirmation, expansion, contradiction or a telling of 
different ideas (Creswell, 2015).
3  | RESULTS
3.1 | Sample
A	 total	 of	 30	 patients	 comprised	 the	 final	 sample	 of	 the	 study	
(Figure	2).	 All	 patients	 received	 radiotherapy	 and/or	 chemother-
apy. Of 80 potentially eligible patients, 38 were not eligible due to 
a Karnofsky performance status <60 (n = 35: aphasia [n = 13], se-
vere cognitive impairment [n = 9] such as impairments of memory, 
language and thinking; Meyers & Brown, 2006, severe neurologi-
cal impairment [n = 9] to a degree where inpatient treatment was 
required, psychotic/severe stress reactions [n = 4] requiring acute 
psychological treatment), and not being able to speak Danish (n = 3). 
Twelve	of	42	eligible	patients	declined	participation.	A	total	of	30	
patients and 33 caregivers were included. Eighteen patients formed 
a sub-sample as they completed all study requirements for the entire 
study period of 1 year. The response rate for the interviews and the 
PROs are shown in Tables 1 and 2. Missing data were due to neuro-
logical decline or death.
Medical and demographic characteristics of study patients are 
 outlined in Table 3.
F IGURE  2 Participant enrollment
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3.2 | Daily life experiences of patients with 
HGG and their caregivers
A	total	of	278	individual	semi-	structured	telephone	interviews	(length	
of 13–25 min) with HGG patients (n = 30) and their caregivers (n = 33) 
were conducted during a 1- year study period from time of diagnosis. 
More detailed characteristics of the patients and caregivers are out-
lined elsewhere (Piil, Juhler, et al., 2015).
Analysis	of	the	interviews	identified	five	main	themes	(Piil,	Juhler,	et	al.,	
2015), of which three were shared by both patients and their caregivers, 
one theme was identified among patients and one among caregivers, only.
1. The first main theme, individual strategy for acquiring prog-
nostic information revealed two different strategies for ob-
taining additional prognostic information that involved either 
seeking or limiting the amount and content of prognostic 
information.	 At	 time	 of	 diagnosis,	 it	 was	 evident	 that	 there	
were two main strategies regarding prognostic information. 
However, during the oncological treatments, the strategy of 
limiting prognostic information became less apparent, but still 
with the need to oscillate between seeking and limiting strat-
egies depending on individual coping preferences. Patients, 
however, did gradually gain a higher prognostic awareness.
2. The second theme, described how the patients and their caregivers 
shared hope and that the caregivers have a strong feeling of solidarity 
with the patient. Hope was expressed in varying ways e.g. through a 
positive attitude, putting oneself in a better health care position than 
others or focusing on concrete projects (further described in theme 
three). Changes in the expression of hope occurred after tumor pro-
gression or symptomatic deterioration as being more orientated to-
wards quality of life than expectation of survival.
3. The third theme engagement in health promotion activities, involved 
the joining forces of patients and caregivers towards a healthier life-
style. Driven by feelings of hope, a need to become actively involved 
in health promotion activities reached its peak in the postoperative 
phase and during the initial phase of the oncological treatment.
4. The fourth theme (patients only), adjustment to functional limita-
tions emerged from experiences of and responses to the neuro-
logical deterioration resulting in a cognitive and functional 
decline,	 limitations	 of	 daily	 activities	 and	 role	 changes.	 As	
symptoms progressed, patients adjusted to the neurological de-
cline through an ongoing process of becoming aware, adapting 
to the loss of functioning, and altering their lifestyle activities.
5. The fifth theme (caregivers only), role transition from family member 
to caregiver described the changing role from being solely a family 
member to becoming a caregiver. Caregivers were highly engaged 
in the course of the disease and treatment of the patients. 
However, the relationship was often challenged by lack of energy 
and difficulties in managing the patients’ limitations, e.g., the cogni-
tive changes.
3.3 | Health- related quality of life in patients with a 
high- grade glioma
Analysis	 of	 changes	 throughout	 the	 entire	 1-	year	 study	 period	 of	
physical activity levels, Karnofsky performance status, prevalence 
and	 severity	 of	 anxiety/depression	 measured	 by	 the	 HADS	 and	
HRQOL	 as	measured	 by	 the	 FACT-	Br	 scores	was	 performed	 in	 a	
sub- sample group of patients (n = 18) who completed all study 
requirements for the entire study period and presented below. 
Analyses	relying	on	the	primary	sample	of	30	patients	are	described	
elsewhere (Piil, Jakobsen, et al., 2015).
3.3.1 | Physical activity and functional status
Physical activity decreased over time, 89% of the patients being ac-
tive	less	than	3	hr/week.	All	patients	had	a	Karnofsky	performance	
Interview time- point
Patients (average length in 
minutes)
Caregivers (average 
length in minutes)
Interview 1 30 (24) 31 (25)
Interview 2 29 (13) 31 (17)
Interview 3 27 (16) 30 (20)
Interview 4 23 (13) 27 (19)
Interview 5 20 (14) 22 (19)
Post- bereavement interviews - 8 (34)
Interview 1: baseline; Interview 2: week 6; Interview 3: week 28; Interview 4: week 40; Interview 5: 
week 52.
TABLE  1 Response rate for the 
interviews
TABLE  2 Response rate for patient- reported outcomes 
assessment
PRO assessment 
Time- point
FACT- Br Number 
completed (%)
HADS Number 
completed (%)
TP 1 28 (93) 28 (93)
TP 2 29 (97) 29 (97)
TP 3 28 (93) 26 (87)
TP 4 21 (70) 21 (70)
TP 5 18 (60) 18 (60)
FACT-	Br:	Functional	 assessment	of	 cancer	 therapy-	brain	 cancer;	HADS:	
hospital anxiety and depression scale; PRO: patient- reported outcome; 
time- point 1: baseline; time- point 2: week 6; time- point 3: week 28; time- 
point 4: week 40; time- point 5: week 52.
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status	≥70	at	 the	 first	 two	 time-	points,	 and	78%	of	 the	patients	
still	 had	 a	 Karnofsky	 performance	 status	 ≥70	 at	 the	 end	 of	 the	
study.
3.3.2 | Anxiety and depression
There was an improvement of mean anxiety from time- point 1 to 
time- point 5 (p	=	.0095).	No	significant	change	in	depression	scores	
from time- point 1 to time- point 5 was identified (p = .07).
3.3.3 | Quality of Life
The	emotional	well-	being	(EWB)	subscale	of	the	FACT-	Br	improved	
significantly (p = .0023) from baseline (13.8 ± 6.7) to time- point 5 
(18.4	±	4.5;	Piil,	Jakobsen,	et	al.,	2015).	No	significant	changes	were	
identified for the other subscales. However, according to the social 
well- being (SWB) sub- scale the patients scored higher at all time- 
points compared to the normative US values.
The longitudinal MM data are shown in Table 4.
TABLE  3 Medical and demographic 
characteristics for study participants
Patients 
(n = 30)
Caregivers 
(n = 33)
Gender
Male/female 19/11 10/23
Age,	median	(range) 57.9 (29–79) 50 (29–72)
Diagnosis
Glioblastoma Multiforme (GBM) WHO Grade IV 23
Primitive	Neuroectodermal	Tomor	(PNET)	WHO	Grade	IV 1
Gliosarcoma WHO Grade IV 1
Anaplastic	Astrocytoma	WHO	Grade	III 4
Anaplastic	Oligodendroglioma	WHO	Grade	III 1
Surgical procedure
Operation/biopsy 23/7
Unifocal/mutifocal 18/12
Marital status
Married/living with partner 24
Single/divorced/living alone 6
Children living at home 6
Highest level of education
Less	than	or	completed	municipal	primary/9th	or	10th	class 6
Training/learning 13
Higher	education	(≤4	years) 6
Prolonged	higher	education	(≥5	years) 5
Employment status before diagnosis
Full time 19 19
Part time 3
Sick leave, flex job/student 1/0 0/3
Not	employed/early	retirement	&	pension 0/10 3/5
Employment status after diagnosis
Full time/part time 2/4
Sick leave 14
Early retirement/pension 10
Changed conditions relating to caregiver responsibilities after 
diagnosis
15
Carling status
Carling for dependent children 6
Not	caring	for	anyone	else 27
Relationship with patient
Spouse/partner 25
Child/sibling 7/1
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The meta- inferences of the two datasets are represented in the 
MM visual joint display (Table 5).
4  | DISCUSSION OF INTEGRATED RESULTS
This discussion compares and examines the qualitative and quantita-
tive components to evaluate whether the findings are complemen-
tary, contradictory or otherwise linked (Table 5).
4.1 | Distress and control as early responses to 
diagnosis of high- grade glioma
Patients and caregivers explained that they were distressed due 
to the poor prognosis and an unpredictable future. The PROs con-
firmed this narrative as a high level of anxiety among patients was 
found at the time of diagnosis. The need of patients and caregivers 
for information at this early stage is mainly related to the HGG tra-
jectory	and	treatment	options.	A	wish	to	exchange	experiences	with	
other	 patients	 and/or	 caregivers	was	 expressed.	As	 a	 response	 to	
this critical stage of the trajectory, both patients and caregivers fol-
lowed individual strategies for acquiring prognostic information. 
Moreover, they needed prognostic information to be provided with 
empathy and in an amount, content and pace that allowed effective 
assimilation.
Individual strategies for acquiring prognostic information functioned 
as a tool for the study participants to integrate and understand the 
reality.	No	standard	approach	for	measurement	of	prognostic	aware-
ness	 currently	 exists	 (Applebaum	 et	al.,	 2014).	 Patients,	 however,	
did gradually gain a higher prognostic awareness. This is supported 
by literature identifying that prognostic awareness can be achieved 
through interactions with skilled professionals (Jackson et al., 2013). 
Our data indicate that whether early prognostic awareness is a pre-
requisite	for	successful	coping	and	for	HRQOL	depends	on	individual	
TABLE  4 Longitudinal	mixed	methods	data	and	meta-	inferences	at	five	time-	points
Time
Critical event 
type
Quantitative results (patients only) Qualitative findings
MetainferencesHADS HRQOL
Physical 
activity and 
KPS
Shared patient and 
caregiver issues
Either patient or 
caregiver issues
TP 1 Neurosurgery	
(biopsy or 
operation)
High level 
of anxiety
Close 
relation 
between 
EWB and 
anxiety
KPS and level 
of physical 
activity 
decreased 
over time
Distressed due to the 
poor prognosis and an 
unpredictable future
Highly engaged in the 
course of the 
disease and 
treatment of the 
patients (caregivers)
Distress and seeking 
control as early 
responses to HGG 
diagnosisIndividual strategies for 
acquiring prognostic 
information
TP 2 Oncological 
treatments
Continuous 
risk of 
depres-
sion
Varying 
periods of 
disease 
stability
Need	for	information	
related to the HGG 
trajectory and 
treatment options
Ongoing role 
transition from 
family member to 
caregiver 
(caregivers)
Being pro- active and 
receiving social 
support are valuable 
for EWB
A	wish	to	exchange	
experiences with peers
TP 3 Response scan 
and 
treatment 
evaluation
High SWB at 
all test time 
points
Activity	
restriction
Engagement in health 
promotion activities, 
patients ended 
utilisation	of	CAT	
(during symptom 
progression)
Hope is essential for 
HRQOL
Shared hope in the 
beginning and later a 
need for redefining 
hope
TP 4 Response scan 
and 
treatment 
evaluation
Searching worldwide 
for advice and 
experimental trails
Caregivers capacity 
and commitment are 
challenged
TP 5 Response scan 
and 
treatment 
evaluation
EWB 
improved 
over time
One- year 
survivors 
have 
highest KPS
Altered	priorities Adjustment	to	
functional 
limitations (patients)
Patient experience 
symptom progres-
sion and neurologi-
cal deterioration
CAT:	complementary	and	alternate	therapy;	EWB:	emotional	well-	being;	HADS:	The	Hospital	Anxiety	and	Depression	Scale;	HGG:	high-	grade	glioma;	
HRQOL:	health-	related	quality	of	life;	KPS:	Karnofsky	performance	status;	SWB:	social	well-	being;	TP:	time-	point.
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preferences. Prognostic awareness enables medical decision- making, 
which might be a motivation for obtaining prognostic information. 
In this way, acquired prognostic information strategies can be com-
pared with coping, as described in the literature as a healthy, paced 
integration of information (Jackson et al., 2013). This is supported by 
a preference for being able to live a normal everyday life for as long 
as possible by participating in everyday activities.
The qualitative findings show that patients become more inter-
ested in greater amounts of prognostic information as time passes 
which is consistent with the quantitative results suggesting that pa-
tients gradually succeed in reducing levels of anxiety. Easy access to 
brain cancer specialists facilitates this process, and more individually 
tailored information and an introduction to palliative care teams are 
recommended (Temel et al., 2010).
4.2 | A proactive attitude and social support improve 
emotional well- being
During oncological treatment, patients and their caregivers described 
how they joined forces in fighting the HGG prognosis together, sup-
ported	by	friends	and	family.	An	imminent	need	to	be	actively	involved	
in ways to optimise the therapeutic effect of the standard oncological 
treatments	and	to	 improve	survival	was	 identified.	A	lack	of	profes-
sional support and information about complementary and alternative 
therapies meant that some patients and caregivers searched world-
wide for advice and experimental trials.
Concerns have been raised that a lack of knowledge about com-
plementary and alternative therapies undermines the ability of pro-
fessionals to communicate the risks and benefits of complementary 
TABLE  5 Overarching meta- inferences for the 1- year illness trajectory
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and alternative therapies (Chang & Chang, 2015). Similar to previous 
studies (Halkett et al., 2015; Janda et al., 2007) the SWB score was 
higher than the normative values at all time- points, supporting that 
the expressed feeling of solidarity between patients and caregivers is 
valuable. Moreover, being pro- active and involved is described in the 
interviews as being related to well- being and may affect the EWB of 
the patients positively, explaining the significant increase in the EWB 
(p = .0023) at 1- year. This is supported by the literature that identi-
fies healthier lifestyle changes as a key component of taking control 
(Lovely	et	al.,	2013).	Some	of	the	ways	our	study	participants	achieved	
this was by incorporating new dietary plans with healthy eating habits, 
reducing smoking and alcohol consumption, using complementary and 
alternative therapies and by trying to be more physically active. Finally, 
a	change	in	the	individual’s	self-	evaluation	or	altered	priorities	(Adams	
et al., 2005) could be connected with the increase in EWB. A declared 
wish for a high level of physical activity was in contrast with the pa-
tients’ PROs on level of physical activity and the measured functional 
performance that decreased over time.
4.3 | Hope is essential for health- related quality of  
life
The awareness that HGG is a life- threatening disease resulted in dis-
tress and a mutual facilitation of shared hope between the patient 
TABLE  6 Needs	and	preferences	of	patients	with	HGG	and	their	caregivers
Patient needs and preferences Patient and caregiver needs and preferences in common Caregiver needs and preferences
Supportive care needs
• Screening for depression 
throughout the trajectory
•	 Assistance	and	help	from	
relatives and health care 
professionals
•	 Anxiety	reducing	interventions	at	time	of	diagnosis
• Optimisation of the patients situation through health 
promoting activities
• Help to obtain, maintain or redefine hope and to discuss hope 
with professionals
• Practical help and support from family and friends
• Exchange of experiences with other patients and/or caregivers
•	 Living	a	normal	everyday	life	for	as	long	as	possible	by	
participating in everyday activities
• Receipt of mutual support between patients and caregivers
• Supportive care interventions tailored to 
individual psychosocial needs
• Easing of their burden by family and 
friends (practically, emotionally, socially)
• Help and information to manage new 
responsibilities (e.g. financial, social and 
care)
• Encouragement from professionals who 
acknowledged them as an essential 
resource
Educational and information needs
• Information about the likely HGG trajectory and treatment 
options
• Individual assistance with how to manage functional and daily 
adjustments
• Information and discussions about health promotion activities 
and complementary and alternate therapy
• Delivery of PI with empathy and at a pace that allows effective 
assimilation
• Improved access to brain cancer specialists throughout the 
HGG trajectory
• Individually tailored information, including introduction to 
palliative care teams
• Easy access to information and specialists in brain cancer
• Respect shown toward their chosen strategies for acquiring PI
• Education in strategies for life planning
• Information about how to manage brain 
cancer-related problems and symptoms, 
e.g. an introduction to the health care 
system
Rehabilitation needs
• Interventions focusing on 
cognitive and physical 
function
• Rehabilitative programmes to 
target cognitive ability to 
participate activity
• Being as independent as 
possible for as long as 
possible
•	 Attending	local	training	
programmes due to transpor-
tation issues and social needs
• Exercising with friends or 
other patients with similar 
challenges
HGG: high- grade glioma; PI: prognostic information.
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and the caregiver. Patients and caregivers were hopeful that their 
situation would turn out better than the survival statistics. This study 
confirms that hope is a source of strength that helps individuals to 
keep going (Coolbrandt et al., 2015; Sterckx et al., 2015), brings pur-
pose and meaning to life, encourages a positive attitude and improves 
psychological well- being (Sutton, 2013). However, both patients and 
caregivers said that they had an unmet need to be supported by pro-
fessionals concerning hope, which was rarely discussed with profes-
sionals	despite	its	vital	importance	for	HRQOL	(Clayton	et	al.,	2008).
Some patients and caregivers succeeded with mutual help to re-
define hope,	shifting	focus	from	survival	to	HRQOL	issues.	According	
to	 Cella	 et	al.,	 hope	 is	 embedded	 in	 the	 EWB	 subscale	 of	 FACT-	Br	
(Weitzner et al., 1995), whereas, interestingly, the sub- sample analysis 
(n = 18) identified a significant increase (p = .0023) in the EWB after 
1 year. This result could be explained by the fact that patients who 
were survivors at 12 months were more hopeful than those who filled 
out	FACT-	Br	shortly	before	their	death.	If	hope	diminishes,	however,	it	
might increase the risk of depression. EWB also has a positive correla-
tion with the level of functional status (Rooney et al., 2013).
The 12- month survivors (n = 18) had higher performance status 
compared to the primary sample (n = 30) throughout the study, which 
could be the reason for the increase in the EWB. Furthermore, the 
self- reported level of anxiety of patients decreased over time, with 
correlations to EWB, possibly indicating that they gained value from 
the shared hope and strong feeling of connection they had together.
4.4 | Symptom progression and neurological 
deterioration
Patients experienced varying periods of disease stability with no or 
few symptoms and/or complications during the trajectory. Symptoms, 
however, eventually increased in number and severity, often result-
ing in rapid neurological deterioration. Brain cancer related symptoms 
expressed as fatigue and quantitatively measured in a decreasing per-
formance status caused activity restrictions not only in social relations 
but also in working life, daily activities and in level of physical exercise.
Maintaining independence for as long as possible was a priority. 
Patients adjusted to the neurological disorders in an ongoing process 
of becoming aware of and adapting to loss of functioning. They experi-
enced trouble in understanding and following instruction(s), difficulties 
in coordinating movements and/or unpleasant symptoms when attend-
ing general rehabilitation programmes. They preferred to exercise at 
their local facilities as it was convenient and fulfilled certain social needs.
Depression has been identified as being part of a symptom cluster 
(Fox,	Lyon,	&	Farace,	2007).	Furthermore,	impairment	of	physical	con-
dition and fatigue (Taphoorn et al., 2005) have been found to cause se-
vere	limitations	in	daily	activities	and	reduce	QOL	(Jones	et	al.,	2010)	
followed by distressful emotional and psychological reactions such as 
depression	(Boele,	Klein,	Reijneveld,	Verdonck-	de	Leeuw,	&	Heimans,	
2014; Molassiotis et al., 2010). Finally, brain tumour histology and 
grade of malignancy affect the production and release of biological 
factors that cause depressive symptoms (Starkweather et al., 2011), 
patients being at risk for unrecognised and untreated depression.
In contrast, our sub- group analysis (n = 18) identified a decreas-
ing tendency for depression over time (not significant, p = .07). This 
indication is supported by studies identifying patients with HGG that 
report	 an	 acceptable	 QOL	 during	 oncological	 treatments	 (Lucchiari	
et al., 2015). Still, moderate cases of depression are identified at each 
time-	point.	Moreover,	 depressive	 symptoms	 according	 to	HADS	 do	
not necessary reflect a clinical depression. It may be difficult, in clini-
cal practice, to distinguish between “understandable” sadness (Singer 
et al., 2011) and vegetative symptoms of depression, such as loss of 
interest, emotion and energy as there are not systematically using 
measurements tools (Weitzner, 1999). Clinical guidelines for diagnos-
ing depression in patients with a glioma have been suggested (Rooney, 
Brown, Reijneveld, & Grant, 2014).
To manage the symptoms and changes, patients need assistance 
from their relatives, their closest relation becoming their closest care-
giver. Consequently, providing the patients and caregivers with infor-
mation about symptom management via readily available specialists 
is recommended. During symptom progression, patients ended their 
utilisation of complementary and alternate therapy, explaining that it 
had doubtful effects, was too expensive and time consuming.
4.5 | Caregivers’ capacity and commitment
The present study shows that the caregivers possess a significant ca-
pacity to be engaged in the care and support of the patient with HGG. 
As	 confirmed	 in	 the	 literature	 (Hricik	 et	al.,	 2011;	 Sherwood	 et	al.,	
2006), commitment to the role of caregiver is nonetheless challenged 
by an enormous caregiver burden, which in many ways is similar to the 
experience	of	caregivers	to	patients	with	Alzheimer’s	disease	(Clare,	
2003).	As	the	patients’	symptoms	put	a	strain	on	the	caregivers’	en-
ergy level and social relationships, they need support tailored to their 
individual psychosocial needs, e.g., practical assistance, emotional 
support, financial information, household tasks and caring tasks (new 
responsibilities). The patients rely on their family members’ ability to 
support them, and information on how to navigate in the health care 
system is necessary knowledge for caregivers. Moreover, caregivers 
preferred encouragement from professionals as they often acknowl-
edged them as essential contributors to the patients’ well- being.
4.6 | Needs and preferences
An	overview	of	 the	 needs	 and	preferences	 extracted	 from	 the	meta-	
inferences is presented in Table 6. The present study identified that 
needs change dynamically along the 1- year process of the HGG trajec-
tory depending on the state of disease and individual preferences rather 
than a specific time- point. Patients and caregivers share certain needs, 
e.g., psychosocial needs. However, separate needs were also identified 
such as patients’ needs for symptom management and rehabilitation, 
while caregivers need support in managing the changed life situation in-
cluding	their	new	responsibilities.	Needs	and	preferences	are	outlined	ac-
cording to supportive care, education and information and rehabilitation.
The methodological strengths of this study include its longitudinal 
design identifying the changing life situation, needs and preferences of 
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patients with HGG and their caregivers. The MM design allowing com-
plementary but different methodological tools to provide multiple per-
spectives on the overall research aim also enhances validity (Bishop & 
Holmes,	2013;	Polit	&	Beck,	2004).	A	further	advantage	is	the	serial in-
terviewing with a homogeneous patient sample and their caregivers, which 
adds knowledge about the life situation of the specific HGG population 
as well about the relationship between the patients and their caregivers 
(Kendall et al., 2009). Guidelines for critiquing MM studies have been 
followed (Polit & Beck, 2012) and the MM approach is believed to have 
strengthened the conclusions. For example, before MM integration we 
knew that patients said they were distressed after being diagnosed and 
found support from their informal caregivers, and now this is confirmed 
for the quantitative measurements of anxiety that decreased from time 
of diagnosis, SWB is scored high and EWB that increased over time.
Limitations of this study include a small sample size for the quan-
titative component. The subsample (n = 18) represent survivors and 
most likely are not necessarily representative for the patient pop-
ulation, and therefore results should be interpreted with caution. 
Extensive qualitative data were gathered from study participants 
representing various demographic characteristics (gender and age). 
However, patients who declined participation (n = 12) might have 
had experiences that could have expanded these findings. Cognitive 
impairments	 frequently	occur	 in	patients	with	HGG.	No	study	par-
ticipants were excluded once enrolled. Those subjects with the most 
severe symptoms, emotional status or social support may have been 
the most likely ones to decline or drop out during the study period. 
This could bias the findings towards the most physically, emotion-
ally, and socially healthy participants. While it is plausible that for 
those with an even more serious situation to be similar, the factors 
noted here may be significantly more rapidly occurring and worse in 
magnitude. Consequently, care should be taken not to extrapolate 
these findings to all HGG patients and caregivers without caution. 
Nonetheless,	 these	 findings	 do	 represent	 the	 perspectives	 of	 our	
participants the longitudinal data collection allowing for a compre-
hensive assessment.
5  | CONCLUSIONS AND CLINICAL  
IMPLICATIONS
The present findings provide a comprehensive understanding regard-
ing needs and preferences of the patients and caregivers for rehabili-
tation and supportive care during a 1- year HGG trajectory. Patients 
and caregivers share some needs but individual and different needs 
were identified, indicating that the HGG trajectory is a dynamic pro-
cess experienced differently by patients and caregivers. The needs 
and preferences among patients and caregivers include interventions 
aimed to maintain hope after diagnosis, early initiated health promo-
tion activities, strategies for symptom management and life planning. 
Patients and caregivers shared a similar need for empathy during pa-
tient education, wishing to receive information at a pace that would 
allow effective assimilation.
Symptoms increase in number and severity over time, often re-
sulting in rapid neurological deterioration. However, patients also 
experience periods of disease stability. Patients are at risk for unrec-
ognised depression throughout the trajectory, because functional 
limitations and tumour progression are related to prevalence of 
depression. Maintaining independence is a main priority of the pa-
tients, rehabilitative programs targeting the cognitive ability should 
help the patient to participate actively in everyday life. Following 
improvement of anxiety, EWB develops during the 1- year trajec-
tory. Interventions aimed to decrease the anxiety are important in-
cluding social support, physical independence and optimisation of 
the life situation. Caregivers have a unique commitment to assist 
the patient and wish to be acknowledged, involved and encouraged 
for their contribution by health care professionals.
This study supports health care professionals in understanding 
the impact of a HGG diagnosis on daily life in patients and their 
caregivers during a 1- year disease and treatment trajectory. Our 
findings contribute to the existing knowledge about the needs and 
preferences of the patients and caregivers and should be incorpo-
rated into future clinical guidelines for rehabilitation and supportive 
care. Guidelines implemented in clinical practice have the potential 
to	 improve	HRQOL	 of	 the	 patients	 and	 support	 caregivers	 by	 in-
volving them more actively in care and management. Health care 
professionals are enabled to take appropriate measures to meet 
these needs and preferences by taking into consideration the early 
and late psychosocial needs and individual preferences for prognos-
tic information. Furthermore, incorporating communication about 
hope and discussions regarding health promoting strategies might 
well improve the quality of care and facilitate the decision- making 
and involvement of the patient in treatment, symptom management 
and life planning.
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